Halozyme Therapeutics Inc Financial Flexibility Index
Halozyme Therapeutics Inc financial flexibility index. Halozyme Therapeutics Inc (HALO) has a Financial Flexibility Index of 0.11x as of September 2025. Free cash flow of $181.63 Million (operating CF $178.60 Million minus capex $3.03 Million) represents 0% of total liabilities ($1.72 Billion). Explore HALO capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Halozyme Therapeutics Inc (2001–2024)
Financial flexibility index of Halozyme Therapeutics Inc from 2001 to 2024. Historical Financial Flexibility Index trend for Halozyme Therapeutics Inc across 24 annual periods. Check HALO capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Halozyme Therapeutics Inc Financial Flexibility Index by Year (2001–2024)
Halozyme Therapeutics Inc financial flexibility index by year from 2001 to 2024. Year-by-year free cash flow to debt coverage for Halozyme Therapeutics Inc. For the full cash flow conversion analysis, see Halozyme Therapeutics Inc cash conversion from operations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.29x | $489.76 Million | $479.06 Million | $1.70 Billion | ▲ +17.7% |
| 2023 | 0.24x | $403.87 Million | $388.57 Million | $1.65 Billion | ▲ +67.1% |
| 2022 | 0.15x | $244.92 Million | $240.11 Million | $1.67 Billion | ▼ -55.8% |
| 2021 | 0.33x | $300.90 Million | $299.44 Million | $907.48 Million | ▲ +145.4% |
| 2020 | 0.14x | $57.96 Million | $55.45 Million | $428.88 Million | ▲ +178.7% |
| 2019 | -0.17x | $-81.38 Million | $-85.42 Million | $474.11 Million | ▲ +26.7% |
| 2018 | -0.23x | $-44.84 Million | $-49.50 Million | $191.36 Million | ▼ -153.9% |
| 2017 | 0.43x | $135.40 Million | $134.05 Million | $311.58 Million | ▲ +370.4% |
| 2016 | -0.16x | $-47.25 Million | $-50.38 Million | $294.00 Million | ▲ +35.8% |
| 2015 | -0.25x | $-34.72 Million | $-37.08 Million | $138.79 Million | ▲ +32.4% |
| 2014 | -0.37x | $-46.15 Million | $-47.52 Million | $124.62 Million | ▲ +4.1% |
| 2013 | -0.39x | $-47.04 Million | $-49.34 Million | $121.78 Million | ▲ +47.3% |
| 2012 | -0.73x | $-62.92 Million | $-64.33 Million | $85.87 Million | ▼ -19.9% |
| 2011 | -0.61x | $-33.52 Million | $-34.35 Million | $54.86 Million | ▲ +3.0% |
| 2010 | -0.63x | $-44.74 Million | $-45.39 Million | $70.99 Million | ▼ -14.4% |
| 2009 | -0.55x | $-38.69 Million | $-40.15 Million | $70.25 Million | ▲ +1.5% |
| 2008 | -0.56x | $-34.21 Million | $-35.37 Million | $61.18 Million | ▼ -1252.2% |
| 2007 | 0.05x | $2.22 Million | $-147.66K | $45.69 Million | ▼ -85.0% |
| 2006 | 0.32x | $7.44 Million | $7.08 Million | $23.01 Million | ▲ +105.9% |
| 2005 | -5.49x | $-12.65 Million | $-13.00 Million | $2.30 Million | ▼ -15.8% |
| 2004 | -4.74x | $-7.49 Million | $-7.72 Million | $1.58 Million | ▼ -257.1% |
| 2003 | -1.33x | $-49.73K | $-49.73K | $37.45K | ▲ +75.2% |
| 2002 | -5.35x | $-55.78K | $-55.78K | $10.43K | ▲ +48.8% |
| 2001 | -10.45x | $-34.37K | $-34.37K | $3.29K | — |